Fixed costs$54.4K/mo
Base monthly overhead
Contribution margin77.5%
After variable spend
Break-even revenue$70.2K/mo
Monthly revenue target
Break-even timingMonth 1
Launch month
Break-even calculator
Test monthly revenue, variable expenses, and fixed monthly costs to see when a regenerative treatment clinic clears break-even.
Money available to cover fixed costs$858,537
$1,071,833 revenue - $213,296 variable expenses
Margin ratio
80%
Covers fixed costs
Yes
Break-even chart Revenue Total costs
Which stem cell clinic expenses are fixed, and which move with treatment volume?
Cost classification
Your break-even model is only useful if fixed overhead stays separate from treatment-linked spend. In this model, Month 1 break-even depends on recurring overhead, stepped clinical payroll, and revenue-linked inputs, not the $695,000 launch buildout.
Expense
Cost
Break-Even Treatment
Common Mistake
Medical Facility Lease — $15,000/month
Fixed
Include the full monthly lease in fixed overhead from Month 1 through Month 60.
Spreading rent across treatments and hiding quiet-month burn.
Malpractice Insurance — $4,500/month
Fixed
Model it as a monthly operating obligation, even when treatment volume is low.
Treating malpractice coverage as a percent of revenue.
Electronic health record (EHR) and IT Systems — $2,200/month
Fixed
Carry the full system cost in monthly fixed overhead.
Making core clinical software variable because patient charts increase.
Compliance and Accreditation — $1,800/month
Fixed
Keep it in fixed overhead because it supports the licensed clinic, not one procedure.
Moving compliance below break-even as discretionary spend.
Medical Director Salary — $320,000/year
Fixed
Convert to about $26,667/month and include it before contribution margin.
Excluding leadership payroll because procedures drive revenue.
Clinical support staffing
Semi-fixed
Step headcount with scale: registered nurses and medical assistants rise from 2 to 6 FTE, and patient coordinators rise from 1 to 3 FTE.
Modeling payroll as fully variable per treatment.
Biologic Procedure Kits
Variable
Subtract as a direct treatment input tied to revenue under the model rate.
Setting kits as a flat monthly inventory budget.
Patient Acquisition Marketing
Variable
Apply it as revenue-linked marketing spend in the break-even margin.
Counting all marketing as fixed overhead and overstating unit margin.
How does break-even shift from a lean launch to a base case and fuller schedule?
Scenario table
Here’s the quick math: consult conversion, treatment package mix, provider capacity, and overhead scaling move break-even more than the headline price list. The lean launch clears fixed costs, the base case adds cushion, and the Year 5 fuller schedule has the widest margin if volume holds.
Planning assumptions only; actual break-even depends on mix, fill rate, and staffing.
Scenario
Monthly Revenue
Variable Costs
Fixed Costs
CM Ratio
Operating Profit
Break-Even Signal
Year 1 lean launch
$314,000
$70,700
$92,450
77.5%
$151,100
Above break-even, but the cushion is still modest.
Year 2 base case
$610,000
$129,320
$111,800
78.8%
$369,300
Comfortable cushion if conversion and staffing stay steady.
Year 5 fuller schedule
$2,147,000
$371,400
$152,800
82.7%
$1,623,000
Largest cushion, though demand still needs to be proven.
What could push this clinic off its break-even cushion?
Stress test
Year 1 has a strong cushion: about $314,000 in monthly revenue against about $92,450 in fixed costs. The break-even risk is a faster revenue drop, a higher staff and lease load, or a small margin slide; those still keep the clinic above break-even, but they tighten the room fast.
Stress Case
Changed Assumption
Break-Even Revenue
Revenue Gap
Risk Signal
Current plan
No change.
$119,000
$195,000 cushion
Healthy cushion, but overhead is still heavy.
Revenue shortfall
Monthly revenue falls 20% to about $251,000.
$119,000
$132,000 cushion
Still above break-even, but the cushion shrinks fast.
Fixed-cost pressure
Fixed costs rise 10% to about $101,700 a month.
$131,000
$183,000 cushion
Lease, insurance, and staffing pressure move break-even up.
Margin pressure
Contribution margin slips 5 points to 72.5%.
$128,000
$186,000 cushion
A small spread hit adds real break-even risk.
Combined pressure
Revenue drops 20%, fixed costs rise 10%, and margin slips to 72.5%.
$140,000
$111,000 cushion
Still profitable, but only about $81,000 operating profit.
What should the founder verify before signing the lease and hiring for a stem cell therapy clinic?
Founder checklist
Before you sign the lease or add staff, confirm that early demand can support $92,450 a month in fixed overhead and payroll. If Month 1 conversions are soft, delay Year 2 hiring and protect the $756,000 cash cushion.
1Demand proof$3.772M Y1
Verify the first-year patient pipeline can support $3.772 million in revenue before you sign space, because break-even only holds if demand shows up right after launch.
2Provider coverage8 FTE Y1
Confirm the opening team can run the Year 1 mix, including the $320,000 Medical Director, and do not move to the Year 2 12-FTE ramp until volume proves it.
3Fixed load$92.45K/mo
Lock monthly fixed costs and payroll at $92,450, including $4,500 malpractice and $1,800 compliance, because that is the burn the clinic must clear every month.
4Margin check77.5% CM
Check that biologic kits, lab processing, patient acquisition marketing, and supplies stay within the 22.5% Year 1 variable load, or the contribution cushion shrinks fast.
5Cash cushion$756K M2
Keep at least $756,000 of cash through Month 2, since capex peaks early and the clinic cannot absorb a slow ramp without reserve.
6Launch spend$695K capex
Separate the $695,000 buildout and equipment spend from monthly operating math before launch, so one-time cash needs do not hide the break-even test.
Choosing a selection results in a full page refresh.